The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Spectrum of neurocognitive impairment in cirrhosis: Implications for the assessment of hepatic encephalopathy†
Abstract
Cirrhosis and chronic liver disease adversely affect neurocognitive functioning.1 These deficits range from neurological complications such as hepatic myelopathy to cognitive and mental status changes such as hepatic encephalopathy (HE).2 These neurocognitive difficulties can also severely restrict the patient's functioning and result in morbidity and mortality.3-6 The most prominent neurocognitive complication of cirrhosis is HE, which reflects a spectrum of neuropsychiatric abnormalities seen in patients with liver dysfunction after exclusion of other known brain disease.7 The current system for studying HE is based on a subjective clinical classification largely based on mental status changes, the West Haven scale.2, 7-9 In addition to the mental status changes detected by clinical scales such as the West Haven scale, there are significant neurocognitive disturbances in those with normal mental status, which is characterized by impaired neuropsychological and perceptual motor dysfunction.10 The current system of HE classification does not take into account the continuum of this neurocognitive dysfunction in HE, which forms a spectrum of neurocognitive impairment in cirrhosis (SONIC).7, 11, 12 This spectrum spans a patient's performance from normal to overt HE to coma. The continuous nature of these impairments is supported by the presence of psychometric and neurophysiological impairments in patients even before they reach overt HE,13 poorer performance on tests in patients with treated overt HE than those without overt HE,1, 14 and persistence of psychometric deficits even after adequate resolution of an episode of overt HE.15 In addition, the worse clinical outcomes in patients with poor psychometric performance as a continuous measure have also been described.16 This review focuses on the available techniques and systems for characterizing HE and discusses the need for an approach for gauging severity of early HE as a continuum based on relevant clinical outcomes. The overall neurological complications of cirrhosis can be HE-related or independent of HE, and it is important to review these separately. Patients with cirrhosis can benefit from a detailed neurological examination; traditional teaching is that patients with difficulties in consciousness who also exhibit focal neurological deficits do not have HE. However, there is a high prevalence of focal deficits in patients with cirrhosis that is unrelated to HE, which may be due to (1) prior alcohol use resulting in cirrhosis and focal deficits, such as neuropathy and cerebellar signs17; (2) direct effects of cirrhosis on the nervous system, such as hepatic myelopathy and extra-pyramidal signs18, 19; (3) deficits unrelated to liver disease, such as residual deficits of prior strokes; and (4) diseases that affect the brain and liver concurrently, such as Wilson's disease.20 Therefore, the mere presence of focal deficits does not specifically exclude HE. Existing focal neurological deficits are also dependent on the depth of examination. A study by Krieger et al.21 revealed that 50% of patients with HE had "focal neurological signs"; these signs were mostly observed in those with a history of prior overt HE. However, most patients that have been included in recent studies do not have any specific focal neurological signs. Hepatic myelopathy is diagnosed as a spastic paraparesis and hyperreflexia without sensory loss; it does not improve with HE therapies but can reverse after liver transplantation.22, 23 Less than 1% of cirrhotic patients also present with acquired hepatolenticular degeneration with extrapyramidal and cerebellar symptoms. Unlike hepatic myelopathy, this responds to HE therapy.18 Although the above syndromes are important in our overall understanding of the neurological complications of cirrhosis, HE remains the most prevalent of these complications. BDT, Block Design test; CFF, critical flicker frequency; DST, digit symbol test; EEG, electroencephalogram; HE, hepatic encephalopathy; HESA, hepatic encephalopathy scoring algorithm; ICT, inhibitory control test; MHE, minimal hepatic encephalopathy; NCT-A/B, number connection tests A/B; PHES, Psychometric Hepatic Encephalopathy Score; RBANS, repeatable battery for assessment of neuropsychological status. HE is clinically divided into normal or overt HE. However when psychometric or neurophysiological tests are also used, it can be divided into normal, minimal HE (MHE), and overt HE.7, 24 This is because minimal HE cannot be diagnosed using just the clinical examination without these specialized tests. The well-known West Haven criteria have been used in several studies, but these criteria suffer from a lack of consistency in their application (Table 1).9, 24 There is a lack of reproducibility apart from the extremes of consciousness.24 Recent studies have shown that there is good agreement among observers in grading patients who are in a coma and those who are completely alert.7, 25 The Gl
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ASSESSMENT OF COMA AND IMPAIRED CONSCIOUSNESS
Teasdale, G., & Jennett, B. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91639-0 · Cited by 13,215
Wechsler Adult Intelligence Scale-III
Ryan, J. J., & Lopez, S. J. (2001) · Understanding Psychological Assessment · doi:10.1007/978-1-4615-1185-4_2 · Cited by 3,731
Ferenci, P., Lockwood, A., Mullen, K., Tarter, R., Weissenborn, K., & Blei, A. T. (2002) · Hepatology · doi:10.1053/jhep.2002.31250 · Cited by 2,043
Right hemispheric dominance of inhibitory control: An event-related functional MRI study
Garavan, H., Ross, T. J., & Stein, E. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.8301 · Cited by 1,394
Neuropsychological characterization of hepatic encephalopathy
Weissenborn, K., Ennen, J. C., Schomerus, H., Rückert, N., & Hecker, H. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00026-5 · Cited by 796
Conn, H. O., Leevy, C. M., Vlahcevic, Z. R., Rodgers, J. B., Maddrey, W. C., Seeff, L. B., & Levy, L. L. (1977) · PubMed · Cited by 641
Comparison of Lactulose and Neomycin in the Treatment of Chronic Portal-Systemic Encephalopathy
Conn, H. O., Leevy, C. M., Vlahcevic, Z. R., Rodgers, J. B., Maddrey, W. C., Seeff, L., & Levy, L. L. (1977) · Gastroenterology · doi:10.1016/s0016-5085(77)80135-2 · Cited by 628
Prasad, S., Dhiman, R. K., Duseja, A., Chawla, Y. K., Sharma, A., & Agarwal, R. (2007) · Hepatology · doi:10.1002/hep.21533 · Cited by 601
Prognostic significance of hepatic encephalopathy in patients with cirrhosis
Bustamante, J., Rimola, A., Ventura, P.-J., Navasa, M., Cirera, I., Reggiardo, V., & Rodés, J. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80144-5 · Cited by 567
Blei, A. T., & Córdoba, J. (2001) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03964.x · Cited by 527
Cited by
Vilstrup, H., Amodio, P., Bajaj, J., Cordoba, J., Ferenci, P., Mullen, K. D., Weissenborn, K., & Wong, P. (2014) · Hepatology · doi:10.1002/hep.27210 · Cited by 2,056
Self-citationBajaj, J. S., Heuman, D. M., Sanyal, A. J., Hylemon, P. B., Sterling, R. K., Stravitz, R. T., Fuchs, M., Ridlon, J. M., Daita, K., Monteith, P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060042 · Cited by 430
Mechanisms, diagnosis and management of hepatic encephalopathy
Prakash, R., & Mullen, K. D. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.116 · Cited by 324
Persistence of Cognitive Impairment After Resolution of Overt Hepatic Encephalopathy
Bajaj, J. S., Schubert, C. M., Heuman, D. M., Wade, J. B., Gibson, D. P., Topaz, A., Saeian, K., Hafeezullah, M., Bell, D. E., Sterling, R. K., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.02.015 · Cited by 302
Self-citation
Metadata
- Authors
- Bajaj, J. S., Wade, J. B., & Sanyal, A. J.
- Venue
- Hepatology
- Published
- 2009-12
- Volume
- 50
- Issue
- 6
- Pages
- 2014-2021
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2146276801
- Cited by
- 342
- References
- 48
- FWCI
- 11.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Spectrum of neurocognitive impairment in cirrhosis: Implications for the assessment of hepatic encephalopathy†. https://app.cochat.ai/papers/10.1002/hep.23216
- The paper
- Bajaj, J. S., Wade, J. B., & Sanyal, A. J. (2009). Spectrum of neurocognitive impairment in cirrhosis: Implications for the assessment of hepatic encephalopathy†. Hepatology. https://doi.org/10.1002/hep.23216
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.